Black Rock Inc. Bio Xcel Therapeutics, Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Bio Xcel Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 440,685 shares of BTAI stock, worth $1.49 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
440,685
Previous 1,328,061
66.82%
Holding current value
$1.49 Million
Previous $3.75 Million
84.94%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding BTAI
# of Institutions
52Shares Held
8.63MCall Options Held
34.5KPut Options Held
59.4K-
Armistice Capital, LLC New York, NY4.32MShares$14.5 Million0.02% of portfolio
-
Ubs Group Ag1.28MShares$4.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.19MShares$4 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA312KShares$1.05 Million0.0% of portfolio
-
Wells Fargo & Company San Francisco, CA199KShares$670,6630.0% of portfolio
About BioXcel Therapeutics, Inc.
- Ticker BTAI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,022,500
- Market Cap $94.4M
- Description
- BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...